Sort
30,917 grants matching “tumor microenvironment”
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
$633,251Andrea Schietinger · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA
Clinical trials employing cancer vaccine combination therapies
$633,201James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$633,201James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Targeting STAT3 to enhance anti-tumor immunity
$633,201Daniel E Johnson · University Of California, San Francisco · R01 · FY2019 · DE
Harnessing the power of exosomes for non-coding RNA delivery
$633,104Anil K Sood · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · CA
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
$632,875Kooresh Isaac Shoghi · Washington University · U24 · FY2017 · CA
Combination antigen sensing engineered T cell for precise recognition and enhanced elimination of solid tumors
$632,874Kole T Roybal · University Of California, San Francisco · R01 · FY2024 · CA
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$632,873Elias Sayour · University Of Florida · R37 · FY2025 · CA
Novel immunological biomarkers ovarian cancer prognosis
$632,858Brahm H. Segal · Roswell Park Cancer Institute Corp · R01 · FY2018 · CA
Immunological consequences of LINE-1 expression in cancer
$632,855Katherine B Chiappinelli · George Washington University · R01 · FY2025 · CA
Optimizing immunoradiotherapy for HNSCC
$632,764Joseph A Califano · University Of California, San Diego · R01 · FY2024 · CA
Gamma delta T cell based melanoma therapies
$632,718Xiaowei Xu · University Of Pennsylvania · R01 · FY2023 · CA
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$632,596Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2015 · CA
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
$632,407Carla F. Kim · Boston Children'S Hospital · R01 · FY2022 · CA
CELL OF ORIGIN AND THE ROLES OF TUMOR MICROENVIRONMENT IN DERMAL NEUROFIBROMA DEVELOPMENT AND THERAPEUTICS
$632,348The University Of Texas Southwestern Medical Center · · FY2012 · Department of Defense
Targeting B7-H3 in ovarian cancer
$632,310Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Toward Translation of an Immunotherapeutic Nanomedicine for Neuroblastoma
$632,304John Tanner Wilson · Vanderbilt University · R01 · FY2023 · CA
Ultrahigh-throughput imaging of 3D tumor microenvironment at nanoscale
$632,300Yongxin Zhao · Carnegie-Mellon University · R01 · FY2025 · CA
Neuronal Regulation of Low-Grade Gliomagenesis
$632,250Michelle Monje-Deisseroth · Stanford University · R01 · FY2025 · CA
Pacritinib in rel/refr T-cell lymphomas
$632,220Ryan A Wilcox · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung Cancer
$632,185Zihai Li · Ohio State University · R01 · FY2025 · CA
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$632,154Harriet M Kluger · Yale University · K12 · FY2019 · CA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$632,135Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · CA
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
$632,130Jeffrey Noebels · Baylor College Of Medicine · R01 · FY2018 · CA
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
$632,130Jeffrey Noebels · Baylor College Of Medicine · R01 · FY2021 · CA